Bookmarks

Drug Recalls More Than Double Since 2008

A 50 percent increase in drug recalls in the past year is raising fears over the quality of drug manufacturing in the US. Read more...

Study: FDA product recalls shows that more clinical testing wouldn't prevent most problems

With critics questioning whether regulators give medical devices enough scrutiny before approving them for patients, University of Minnesota law Prof. Ralph Hall pored over seemingly obscure regulatory data to determine whether the allegations are true. Read more...

Redefining Risk Management in the Supply Chain

The recent economic challenges have led many companies to revisit their view of risk management. Among other areas of risk, many had to rethink their approach to low-cost country sourcing. Read more...

Transparency to Alter FDA and Industry Practices

The federal transparency campaign is reshaping drug research, production, regulation, and marketing on multiple fronts. Read more...

ICH Q11 Guideline Structure and Content Taking Shape

The structure and content of ICH Q11 on drug substance development and manufacturing is taking shape as the Expert Working Group (EWG) resolves the challenging issues around the guidelines breadth and depth and its relationship to the other guidelines in the ICH quality family Read more...

FDA's Role in Fostering the Development of Better Medical Devices

Infusion pumps rank in the top ten of both the FDA’s medical device adverse event list and the medical device recall list. But 87 recalls in the last five years have not produced the next generation of devices. Read more...

Management and Leadership: Risk and Quality are two sides of the same coin

Without a quality system, quality assurance is at best a guess, with no basis for continuous quality improvement. Read more...

FDA 1572: Big Changes in FAQ Information Sheet Guidance

The FDA has made some big changes in the final version of their Frequently Asked Questions (FAQ), Statement of the Investigator (Form FDA 1572) Information Sheet Guidance for Sponsors, Clinical Investigators, and IRBs (May 2010). Read more...

How to Avoid and Respond to FDA Warning Letters

No regulated business wants to receive an FDA Warning Letter (or Form-483) of Inspectional Observations. In such controlled industries as food, agriculture and pharmaceutical, receiving a list of deficiencies can feel like a heavy blow to your quality system. Read more...

Company-Wide Quality Management Systems – How Do They Differ?

Before discussing company-wide Quality Management systems, it is necessary to define the definition of Quality Management (QM). Many organizations and other groups of individual people have attempted to define QM. There are several different operational definitions of quality that are commonly used in many industries. Read more...

Quality System Management: Procedural Writing Not Always the Answer

Quality Management Systems, such as ISO 9001, serve as the foundational building blocks for an organization and provide well defined and documented procedures which improve the consistency of outputs. Yet, the Quality Management System alone cannot accomplish a system of closed loop corrective actions and instituted lessons learned. Read more...

Supplier Audits Dig Deeper

While supplier audits are not new, many companies have conducted more of them in recent years as they sourced more from suppliers in low-cost regions and because of last year's economic downturn, which challenged the financial solvency of some suppliers. Read more...

Deviations and CAPA most frequent observations in FDA inspections

As seen in the Warning Letter Report issued by the European Compliance Academy (ECA) observations in "Production Record Review" (21 CFR §211.192) are among the most frequent GMP deviations cited by the U.S. Food & Drug Administration (FDA). Read more...

FDA Launches New Initiative to Measure Performance

The FDA announced the launch of its newest initiative, FDA-TRACK, this week. The initiative is designed to help measure the agency’s performance through using a series of quantifiable benchmarks that would give congressional appropriators a clear understanding of how well the FDA uses its money. Read more...

Pathwise Solutions

Through training in PathWise Project Success managers learned a process for the selection and approval of projects. Team leaders and team members acquired the skills to accomplish projects on time and within scope.

Sign up for our newsletter